CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation.
dc.contributor.author | Ma, L | |
dc.contributor.author | Jang, L | |
dc.contributor.author | Chen, J | |
dc.contributor.author | Song, J | |
dc.contributor.author | Yang, D | |
dc.contributor.author | Zhang, J | |
dc.contributor.author | Chen, YE | |
dc.contributor.author | Xu, J | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2022-10-05T14:59:36Z | |
dc.date.available | 2022-10-05T14:59:36Z | |
dc.date.issued | 2019-01-01 | |
dc.identifier.issn | 1940-087X | |
dc.identifier.issn | 1940-087X | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/31282887 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/174900 | en |
dc.description.abstract | Gene editing nucleases, represented by CRISPR-associated protein 9 (Cas9), are becoming mainstream tools in biomedical research. Successful delivery of CRISPR/Cas9 elements into the target cells by transfection is a prerequisite for efficient gene editing. This protocol demonstrates that tube electroporation (TE) machine-mediated delivery of CRISPR/Cas9 ribonucleoprotein (RNP), along with single-stranded oligodeoxynucleotide (ssODN) donor templates to different types of mammalian cells, leads to robust precise gene editing events. First, TE was applied to deliver CRISPR/Cas9 RNP and ssODNs to induce disease-causing mutations in the interleukin 2 receptor subunit gamma (IL2RG) gene and sepiapterin reductase (SPR) gene in rabbit fibroblast cells. Precise mutation rates of 3.57%-20% were achieved as determined by bacterial TA cloning sequencing. The same strategy was then used in human iPSCs on several clinically relevant genes including epidermal growth factor receptor (EGFR), myosin binding protein C, cardiac (Mybpc3), and hemoglobin subunit beta (HBB). Consistently, highly precise mutation rates were achieved (11.65%-37.92%) as determined by deep sequencing (DeepSeq). The present work demonstrates that tube electroporation of CRISPR/Cas9 RNP represents an efficient transfection protocol for gene editing in mammalian cells. | |
dc.format.medium | Electronic | |
dc.language | eng | |
dc.publisher | MyJove Corporation | |
dc.relation.haspart | ARTN e59512 | |
dc.subject | Animals | |
dc.subject | CRISPR-Cas Systems | |
dc.subject | Clustered Regularly Interspaced Short Palindromic Repeats | |
dc.subject | Electroporation | |
dc.subject | Endonucleases | |
dc.subject | Gene Editing | |
dc.subject | Humans | |
dc.subject | Rabbits | |
dc.subject | Ribonucleoproteins | |
dc.subject | Transfection | |
dc.title | CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation. | |
dc.type | Article | |
dc.identifier.pmid | 31282887 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174900/2/2019-jove-RNP-tube-electroporation.pdf | |
dc.identifier.doi | 10.3791/59512 | |
dc.identifier.doi | https://dx.doi.org/10.7302/6529 | |
dc.identifier.source | J. Vis. Exp. | |
dc.description.version | Published version | |
dc.date.updated | 2022-10-05T14:59:35Z | |
dc.identifier.orcid | 0000-0003-2449-8651 | |
dc.identifier.orcid | 0000-0003-2357-7825 | |
dc.identifier.volume | 148 | |
dc.identifier.issue | 148 | |
dc.identifier.name-orcid | Ma, L | |
dc.identifier.name-orcid | Jang, L | |
dc.identifier.name-orcid | Chen, J | |
dc.identifier.name-orcid | Song, J | |
dc.identifier.name-orcid | Yang, D; 0000-0003-2449-8651 | |
dc.identifier.name-orcid | Zhang, J | |
dc.identifier.name-orcid | Chen, YE; 0000-0003-2357-7825 | |
dc.identifier.name-orcid | Xu, J | |
dc.working.doi | 10.7302/6529 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.